7-[4-(N-ACETYL-N-ETHYL)-AMINOPHENYL]-3-(1H-1,2,4-TRIAZOL-3-YL)-PYRAZOLO-[1,5-A]-PYRIMIDINE
Compound with spectra: 1 NMR
![7-[4-(N-ACETYL-N-ETHYL)-AMINOPHENYL]-3-(1H-1,2,4-TRIAZOL-3-YL)-PYRAZOLO-[1,5-A]-PYRIMIDINE](/api/compound/EYjm5oXQjQH.png?ph=true&h=300&w=458 "7-[4-(N-ACETYL-N-ETHYL)-AMINOPHENYL]-3-(1H-1,2,4-TRIAZOL-3-YL)-PYRAZOLO-[1,5-A]-PYRIMIDINE")
| SpectraBase Compound ID | EYjm5oXQjQH |
|---|---|
| InChI | InChI=1S/C18H17N7O/c1-3-24(12(2)26)14-6-4-13(5-7-14)16-8-9-19-18-15(10-22-25(16)18)17-20-11-21-23-17/h4-11H,3H2,1-2H3,(H,20,21,23) |
| InChIKey | OPRKTGJXLSEBLP-UHFFFAOYSA-N |
| Mol Weight | 347.38 g/mol |
| Molecular Formula | C18H17N7O |
| Exact Mass | 347.149458 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
7-methyl-2,5-bis(methylsulfanyl)-3-phenyl-pyrazolo[1,5-a]pyrimidine
pyrazolo[1,5-a]pyrimidine-2-carboxamide, 5-(4-methylphenyl)-N-propyl-7-(trifluoromethyl)-
3-(4-Methoxyphenyl)-7-methyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[4,3-c]pyrimidine
benzoic acid, 4-(2-[(E)-2-(2-hydroxyphenyl)ethenyl]-4-oxo-3(4H)-quinazolinyl)-
2-(2-Naphthalen-2-yl-vinyl)-3-p-tolyl-3H-quinazolin-4-one
2-[4-(4-Amino-5-mercapto-1,2,4-triazo-3-yl)phenyl]-7-methoxy-3-methyl-1(2H)-isoquinolinone
Pyrazolo[1,5-a]pyrimidine, 5,6-dimethyl-7-(1,1-dimethylethyl)-3-phenyl-
2-(4-Bromophenyl)-6,7-dinitro-1H-benzo[de]isoquinoline-1,3(2H)-dione
3,5-DIPHENYL-3,7-DIHYDRO-4-H-PYRROLO-[2.3-D]-PYRIMIDIN-4-ONE
pyrazolo[1,5-a]pyrimidine-6-propanamide, N-(4-chlorophenyl)-5,7-dimethyl-2-phenyl-
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of pyrazolo[1,5-a]-, 1,2,4-triazolo[1,5-a]- and imidazo[1,2-a]pyrimidines related to zaleplon, a new drug for the treatment of insomnia | Journal of Heterocyclic Chemistry | 2001 |